🔍
Search Results - oliver+laeyendecker
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Antibodies associated with HIV control
Value Proposition· Target associated with viral load reduction identified from a large pool of study participants who had low level viremia· Potential to reduce disease severity in at-risk populations· Proactive approach to lower viral load in individuals who could become infected Unmet NeedHuman immunodeficiency virus (HIV) impacts millions...
Published: 3/14/2025
|
Inventor(s):
Susan Eshleman
,
Harry Larman
,
Kai Kammers
,
Oliver Laeyendecker
,
Wendy Grant-McAuley
Keywords(s):
Category(s):
Clinical and Disease Specializations > Infectious Diseases > HIV
,
Clinical and Disease Specializations > Infectious Diseases > HIV/AIDS
,
Technology Classifications > Therapeutic Modalities > Antibodies
,
Technology Classifications > Therapeutic Modalities > Therapeutic Antibodies
HIV Serosignatures for Cross-sectional Incidence Estimation
Unmet NeedAccording to UNAIDS, there were approximately 36.9 million people worldwide living with HIV/AIDS in 2017. An estimated 1.8 million individuals worldwide became newly infected with HIV in 2017 – about 5,000 new infections per day.Measuring the incidence of HIV in a population is important for improving at-risk populations and intervention...
Published: 3/14/2025
|
Inventor(s):
Susan Eshleman
,
Oliver Laeyendecker
,
Harry Larman
,
Kai Kammers
Keywords(s):
Clinical Diagnostics
,
Diagnostic Tool
,
Disease Indication
,
HIV/AIDS
,
Infectious Diseases
,
Measurement Tool
Category(s):
Technology Classifications > Diagnostics > Biomarkers
,
Technology Classifications > Diagnostics > Prognostic Biomarkers
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum